Cees Tijssen

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Martin J. van den Bent, Alba A. Brandes, Martin Taphoorn et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

Martin J. van den Bent, Alba A. Brandes, Marc Sanson et al. · Journal of Clinical Oncology · 2006 · 744 citations

Medicine, Oncology, Radiation Oncology +17

<i>IDH1</i> and <i>IDH2</i> Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

Martin J. van den Bent, Hendrikus J. Dubbink, Yannick Marie et al. · Clinical Cancer Research · 2010 · 381 citations

Medicine, Oncology, Pharmacology +15

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy

Martin J. van den Bent, J. Kros, J.J. Heimans et al. · Neurology · 1998 · 203 citations

Medicine, Oncology, Pharmacology +16

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial

Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Johan M. Kros et al. · Neuro-Oncology · 2015 · 162 citations · Full text

Medicine, Molecular Medicine, Oncology +17